However , when the outcomes were evaluated separately , febuxostat showed an increased risk of heart - related deaths and death from all causes .
The preliminary results show that overall , febuxostat did not increase the risk of these combined events compared to allopurinol .
When the outcomes were evaluated separately , febuxostat showed an increased risk of heart - related deaths and death from all causes .
The preliminary results show that overall , febuxostat did not increase the risk of these combined events compared to allopurinol .